Table 2. Relationship of TRIM6 overexpression to the markers of immune cells in LUAD tissues from the GEPIA2 database.
| Cell type | Markers | r | P |
|---|---|---|---|
| CD8+ T cell | CD8A | 0.089 | 0.051 |
| CD8B | –0.02 | 0.67 | |
| Macrophage | INOS (NOS2) | 0.049 | 0.28 |
| IRF5 | 0.21 | 2.3e-06 | |
| COX2 (PTGS2) | 0.08 | 0.079 | |
| CD163 | 0.2 | 1.1e-05 | |
| VSIG4 | 0.2 | 9.8e-06 | |
| MS4A4A | 0.18 | 9.9e-05 | |
| Neutrophil | CD66b (CEACAM8) | 0.081 | 0.075 |
| CD11b (ITGAM) | 0.23 | 4.4e-07 | |
| Dendritic cell | HLA-DPB1 | 0.11 | 0.014 |
| HLA-DQB1 | 0.063 | 0.17 | |
| HLA-DRA | 0.13 | 0.0034 | |
| HLA-DPA1 | 0.16 | 0.00049 | |
| BDCA-1 (CD1C) | 0.033 | 0.47 | |
| BDCA-4 (NRP1) | 0.29 | 4.7e-11 | |
| CD11c (ITGAX) | 0.16 | 0.00045 |
TRIM6, tripartite motif containing 6; LUAD, lung adenocarcinoma.